Discover how Close-Up empowered a major pharmaceutical company to revolutionize its prescription conversion rates. Dive into our case study and learn how we helped drive substantial revenue growth through strategic interventions.
Navigating the Sales Funnel: Explore the challenges pharmaceutical companies face in converting prescriptions to sales. Learn why enhancing conversion rates is crucial for revenue growth, especially in fragmented markets with fierce competition.
In-Depth Analysis: Delve into Close-Up’s comprehensive analysis of a major pharmaceutical company’s sales of Rivaroxaban branded generic in Brazil. Learn how we identified key factors contributing to subpar conversion rates and devised actionable strategies for improvement.
Strategic Interventions: Discover the strategies Close-Up recommended to address low conversion rates, including targeted promotions, prescriber segmentation, and POS optimizations. See how these interventions led to significant revenue increases and market share growth.
Real Results: Explore the tangible outcomes of Close-Up’s interventions, including a nearly 50% increase in annualized revenue and substantial market share growth within just a few months. Witness the power of data-driven decision-making in driving business success.
Unlock Your Potential: Download our case study now to learn how Close-Up’s data-driven approach can help your pharmaceutical company overcome challenges and achieve unprecedented success in prescription conversion.
Download Now: Don’t miss out on the opportunity to unlock your company’s potential.
Fill out the form below.
Close-Up International serves the pharmaceutical industry for over 55 years. Our efforts towards continuous improvement are the engine of our growth. We like to take on new challenges, providing the latest technology and solutions to maximize the benefits and make our clients’ costs efficient, who we see as true strategic partners.
Close-Up International is a registered trademark of Prescription Data AG, a Swiss entity, and its network of member firms, each one of them constitutes a unique and independent legal entity.
